PHP
XAIR icon

Parkman Healthcare Partners’s Beyond Air XAIR Stock Holding History

Parkman Healthcare Partners’s Portfolio XAIR Stock Details XAIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-316
Closed -$941K – 95
2022
Q3 		$941K Buy
+316
New +$1.19M 0.27% 71

Other funds holding XAIR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Parkman Healthcare Partners's XAIR Position: Q4 2022 in Review

Parkman Healthcare Partners sold out of Beyond Air (XAIR) in Q4 2022, closing a stake of 316 shares — an estimated $941K sold.

Parkman Healthcare Partners first reported a position in XAIR in Q3 2022 and held it in 1 quarter. The position peaked at $941K in Q3 2022. 51 funds tracked by Wall St. Rank hold XAIR as of Q4 2022.

  • Parkman Healthcare Partners reported no remaining Beyond Air position as of Q4 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 316 Beyond Air shares in Q4 2022, an estimated $941K.
  • Parkman Healthcare Partners first reported a position in Beyond Air in Q3 2022 and held it in 1 quarter.
  • Parkman Healthcare Partners's Beyond Air position peaked at $941K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Beyond Air as of Q4 2022.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.